Niall Condon is named as Curia's new CEO

Niall Condon is named as Curia's new CEO ...

ALBANY, New York (BUSINESS WIRE)August 2, 2022

Niall Condon has been appointed as Curia's president of its Manufacturing Division, which will take on the role of operational director of Curias' commercial manufacturing services and products, including API and Drug Product. He will also serve on the Curias executive committee.

This press release includes multimedia. View the whole release here: https://www.businesswire.com/news/home/20220802005165/en/

Curias Manufacturing Division President Niall Condon (Photo: Business Wire)

At this critical point in our growth journey, I am extremely pleased to welcome Niall to Curia, according to Curia's Chairman and CEO John Ratliff. Steve has transformed our manufacturing capabilities over the past few years with a blend of scientific depth and operational excellence. I am confident that Niall will continue to lead global teams across all aspects of the global biopharmaceutical supply chain.

Condon was previously head of Viatris, a company that was merged with Mylan and Upjohn Pfizer. Previously, he was a senior vice president at Pfizer, where he headed a separate global supply company, the Upjohn Division. He earned his Bachelor of Science in Chemical Engineering from Munster Technological University in Ireland, and his Master of Business Administration from Rensselaer Polytechnic Institute in New York.

Condon said she's very excited to join Curia in fulfilling its mission of life-changing science. The CDMO industry is dynamic and Curia is uniquely positioned to serve customers with its innovative portfolio of services and products, which spans R&D through manufacturing. Im looking forward to meeting its talented team of professionals who are making an impact for our customers and the patients they serve.

Curia's Background

Curia, previously AMRI, is a leading contract research, development, and manufacturing company offering services and products to pharmaceutical and biopharmaceutical customers from the start of research through commercial manufacturing. Curias 3,700 employees at 29 locations across the United States, Europe, and Asia help their customers progress from curiosity to cure.

https://www.businesswire.com/news/home/20220802005165/en/view the source version of the article.

You may also like: